|Bid||83.70 x 400|
|Ask||83.71 x 900|
|Day's Range||83.64 - 84.85|
|52 Week Range||69.35 - 89.72|
|PE Ratio (TTM)||28.97|
|Dividend & Yield||1.84 (2.18%)|
|1y Target Est||N/A|
Medtronic (MDT) announces a clinical trial to evaluate one-month dual antiplatelet therapy in patients implanted with the Resolute Onyx Drug-Eluting Stent during PCI procedures.
Medtronic (MDT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP ahead of earnings.
On the hunt for income? Here's why our team of healthcare experts thinks you should check out AbbVie, Medtronic, and ResMed.